Committed to Safe Online Pharmacy NABP
|
|
- Charla Summers
- 5 years ago
- Views:
Transcription
1 Committed to Safe Online Pharmacy
2 What Is.pharmacy? Pharmacy s new Internet namespace
3 What Is NABP? The National Association of Boards of Pharmacy ( ) is the impartial professional organization that supports its member boards of pharmacy in protecting the public health. Member boards include all 50 United States, the District of Columbia, Guam, Puerto Rico, the Virgin Islands, eight Canadian provinces, Australia, and New Zealand.
4 What Is.pharmacy? In 2012, NABP, with the support of a global coalition of stakeholders, applied to the Internet Corporation for Assigned Names and Numbers (ICANN) to own and operate a new generic Top-Level Domain (gtld).pharmacy. A gtld is the text to the right of the dot in a domain name. Words created from letters found in the Latin and Spanish alphabets can be used as.pharmacy domain names. Potential.pharmacy domain names include: Boots.pharmacy lamejorfarmacia.pharmacy Pfizer.pharmacy
5 What Is.pharmacy? Ultimate goal is for patients worldwide to: distinguish a.pharmacy website as legitimate; and know that the medications, information, and services they obtain from that site are authentic and safe.
6 Why.pharmacy? Addresses global concern about illegal online drug sellers distributing products that endanger patient health
7 Why.pharmacy? Supports regulatory efforts of individual countries, states, and territories
8 What are the Global Concerns? NABP research indicates that most websites selling medicine operate illegally and endanger patient health. NABP has reviewed nearly 11,0000 sites and has found over 10,300 (97%) to be in conflict with US federal and state pharmacy laws.
9 What are the Global Concerns? Multiple sites offer to sell foreign or non-food and Drug Administration (FDA)-approved drugs, many of which are thought to be counterfeit. Online sales of unregulated and counterfeit drugs are estimated at $75 billion per year. According to World Health Organization, in over 50% of cases, drugs purchased over the Internet from illegal sites that conceal their physical address have been found to be counterfeit.
10 Counterfeiting Cases The number of US FDA counterfeiting investigations has increased dramatically over the past several years. In 2000, the number of cases initiated was six, while in 2004, 58 cases were opened. In addition, the United Kingdom saw a 270% increase in counterfeiting incidents between 2004 and In June 2005, counterfeit Norvasc was found to have been dispensed from a pharmacy in Canada. Eleven deaths were investigated for a possible link to the counterfeit product.
11 Counterfeiting Cases Counterfeit Lipitor was found in the UK in 2005, resulting in a nationwide recall of 120,000 packages. An analysis revealed that 60% of the recalled product was counterfeit. In an earlier Lipitor counterfeiting incident, 18 million repackaged tablets, a mix of counterfeit tablets and authentic tablets intended for non- US markets, were recalled in the largest recall of a prescription medicine in the US.
12 More Counterfeiting Concerns In 2011, more than 50,000 packages shipped from rogue Internet drug sites were seized and found to contain more than 2.4 million illicit and counterfeit dosage units. FDA has found Counterfeit HIV/AIDS drugs that contained nonsterile tap water instead of an active ingredient, Fake schizophrenia medication containing aspirin, and Misbranded cough suppressant that caused the death of five consumers.
13 Additional Concerns Illegal sale of prescription drugs, including controlled substances, without a prescription One in six Americans has purchased medication via the Internet without a valid prescription.
14 Why Is This a Global Public Health Issue? Illegal prescription drug sales and counterfeit medicines threaten patient safety worldwide. Diseases needlessly left untreated Illness and death due to toxic substances Prescription drug abuse on the rise
15 Additional Concerns Pharmacy spam constituted 31% of all spam during 4Q11. Responsible for computer viruses and malware Ties to international organized crime
16 Earlier Initiatives by NABP Verified Internet Pharmacy Practice Sites (VIPPS ) program Includes policy and procedure evaluation, website review, license verification, and on-site visit Advantages Very thorough evaluation high confidence for consumers Disadvantages VIPPS seal has been hijacked and posted on rogue websites. Applicable only to pharmacy applicants Price may be out of reach for smaller practices. Process may be lengthy. US and Canadian applicants only
17 Earlier Initiatives by NABP NABP e-advertiser Approval CM Program Includes website review and license verification Advantages Shorter processing time and lower cost than VIPPS Applicable to pharmacies with a limited online presence and non-pharmacy applicants Disadvantages E-Advertiser seal may be hijacked US and Canadian applicants only
18 Goals of the.pharmacy gltd Program Restrict use of.pharmacy domain names to legitimate website operators that meet universal Internet pharmacy practice standards. Registrants must demonstrate adherence to all applicable laws where they are located and where their patients reside. Available to pharmaceutical manufacturers, pharmacy benefit management companies, schools and colleges of pharmacy, wholesale drug distributors, drug information sites, and more All current approved VIPPS and e-advertisers will be offered.pharmacy without having to undergo additional evaluation. Keep.pharmacy out of the hands of a third party that may allow illegal and/or counterfeit activity within the gtld
19 How Will.Pharmacy Attain These Goals? Evaluate domestic AND international applicants International partnerships worldwide to assist with screening and monitoring of all.pharmacy domain name registrants for adherence with standards Raise consumer awareness and build trust in the.pharmacy gtld
20 Screening and Monitoring of Applicants All applicants vetted prior to registration Evaluation for compliance with program standards and with regulatory standards in home jurisdiction and jurisdiction of patients Necessary jurisdictional pharmacy and practitioner licensure Only valid prescriptions filled Patient information protected Disciplinary history evaluated
21 Ongoing Compliance Monitoring Approved registrants of.pharmacy domain names will be monitored for continued compliance with standards. Domain names within.pharmacy will be subject to suspension or revocation upon the violation of the terms and conditions set forth in the registration agreements.
22 Support for.pharmacy Is Global Leaders Contributed $100,000 or more Pfizer, Inc Eli Lilly and Company Merck & Co, Inc Advocates Contributed $25,000 or more Gilead Sciences Janssen Therapeutics
23 Support for.pharmacy Is Global Endorsers Submitted a letter of support to ICANN or otherwise publicly expressed support Amgen, Inc, Alliance for Safe Online Pharmacies (ASOP), Boehringer Ingelheim, British Brands Group, Drugsdepot.com, DrugSource, Inc, EnforceTheAct.org, European Alliance for Access to Safe Medicines (EAASM), Indiana Board of Pharmacy, International Pharmaceutical Federation (FIP), Ipsen Pharma, LegitScript, National Association of Pharmacy Regulatory Authorities (NAPRA), North Dakota State Board of Pharmacy, Novo Nordisk, Inc, Rx Direct, Inc, Sanofi
24 Support for.pharmacy Is Global The Supporter Advisory Committee provides expertise and strategic input to the Executive Board for establishing core standards of operation that are universal to legitimate pharmacy practice and that will be required of all.pharmacy domain name registrants. The Supporter Advisory Committee includes: ASOP, California State Board of Pharmacy, Eli Lilly and Company, EAASM, FairWinds Partners, FIP, Indiana Board of Pharmacy, INTERPOL, LegitScript, Merck & Co, Inc, NAPRA, Neustar, North Dakota State Board of Pharmacy, Pfizer
25 .pharmacy Product Model Online and brick-and-mortar pharmacies will likely route the.pharmacy domain name to their current sites in the.com or.net TLD. Geographic names we hope to use geographic names to identify legitimate pharmacies operating legitimately in the geographic location. May be limited permission required from country authorities Germany.pharmacy, france.pharmacy, spain.pharmacy, us.pharmacy
26 Consumer Education Fundamental goal is to educate consumers to recognize.pharmacy as the valid designation for a legitimate pharmacy or pharmacy-related entity. Look to the right of the dot Increase awareness of rogue online drug sellers masquerading as pharmacies Dangers of counterfeit drugs and buying prescription drugs without a prescription As consumer recognition increases, more businesses will be willing to undertake the application process.
27 What Has Been Accomplished So Far? February 2013.Pharmacy gtld Advisory Committee convened May 2013.pharmacy application passed ICANN s initial evaluation July 2013.pharmacy gtld governance document finalized June 2014 contract with ICANN finalized Late 2014 anticipated launch
28 Recent Challenges Name collision issues will delay launch of some domain names. Name collision refers to the confusion that could occur when a new gtld string exactly matches an existing string used on an internal network. As new gtlds go live, they can potentially collide with existing names. Two-letter country codes cannot be used without permission of each country s ICANN Government Advisory Committee representative.
29 Recent Challenges Rogue drug sellers disguised as legitimate pharmacies have been vocal in their opposition to.pharmacy. Spreading misinformation and lies about the program and NABP Accusations of payoffs to NABP by pharmaceutical manufacturers PharmacyChecker Canadian International Pharmacy Association
30 Next Steps Develop international partnerships! Finalize and execute all necessary contracts Finalize domain registration polices and technical operations Launch consumer education campaign
31 Conclusion Success will not be measured by the number of domain names registered. Success will be measured by the level of recognition and trust placed in the.pharmacy domain.
32 VAWD Verified-Accredited Wholesale Distributors (VAWD ) VAWD was launched in 2005 and was developed due to concerns of counterfeit drugs affecting the US drug supply. FDA supported the development of the program. Wholesale distributors of prescription drugs and devices that are located in the US are eligible to apply for VAWD.
33 VAWD In 2013, NABP revised the VAWD criteria. Virtual manufacturers and virtual wholesale distributors could qualify for VAWD accreditation. Responsible distribution practices are mandated. Diverted drugs are prevented from entering into the supply chain.
34 VAWD Complex global supply chain for prescription drugs 80% of Active Ingredients (powder) for prescription drugs from overseas 40% of Finished Dosage Forms (capsules, tablets, liquids) from overseas Accreditation programs track drugs from start (manufacturer) to finish (patient or destruction of non-dispensed expired drugs).
35 VAWD Determine lawful sources to ensure drugs are safe and effective Examine security, storage, shipping of drugs Narrow temperature ranges for most drugs (68 o to 77 o F) Backup power for systems Shipping packaging maintains temperature
36 Monitor and Record Temperature
37 Backup Power for Security and AC Systems
38 Shipping
39 VAWD 21 states recognize VAWD in some manner. There are currently over 540 VAWD-accredited wholesalers.
40 Questions? Carmen A. Catizone Executive Director/Secretary National Association of Boards of Pharmacy 1600 Feehanville Drive Mount Prospect, IL
Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: February 2018
Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: February 2018 Prepared By The National Association of Boards of Pharmacy Table of Contents Introduction...
More informationPrescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study
Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois
More informationFrance: Millions of medicines seized in largest INTERPOL operation against illicit online pharmacies
LYON, France, September 25 (Infosplusgabon) - In the largest action of its kind, INTERPOL s Operation Pangea X, targeting the illicit online sale of medicines and medical devices, has resulted in some
More informationRESPONSE FROM ALTRIA:
RESPONSE FROM ALTRIA: FDA Regulation of Tobacco http://www.altria.com/en/cms/about_altria/federal_regulation_of_tobacco/default.aspx?src=top_nav http://www.fda.gov/tobaccoproducts/default.htm The Food
More informationB.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations
B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations Copyright February 2018, Province of British Columbia. All rights reserved. This material is owned by the Government of British
More informationCardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention
Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention The people of Cardinal Health care deeply about the devastation opioid abuse has caused American families and communities
More informationCounterfeit Pharmaceuticals. in Canada. The counterfeit criminal market. in Canada. No country is immune from counterfeit drugs
Criminal Intelligence Service Canada August 2006 Counterfeit Pharmaceuticals in Canada The counterfeit criminal market in Canada Counterfeit goods can be categorized into industry sectors: entertainment
More informationChanges to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
More information4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch
Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,
More informationGeneration Rx: The Abuse of Prescription and Over-the-Counter Drugs
Subcommittee Hearing Statement Generation Rx: The Abuse of Prescription and Over-the-Counter Drugs United States Senate Committee on the Judiciary Subcommittee on Crime and Drugs and The Senate Caucus
More informationDo not open the test booklet prior to being told to do so.
Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationReport of the Task Force on Drug Diversion through Institutional Outlets
Report of the Task Force on Drug Diversion through Institutional Outlets Members Present: Wiki Erickson (TX); David Flashover (NY); Donald Gibson (MN); Susan Ksiazek (NY); Wallace Nelson (NC). Not Present:
More informationPrescription / Over-the- Counter Drugs
AzPA 6 th Annual Meeting July 18, 2010 The Partnership for a Drug Free America, Arizona Chapter Pamela S. Murphy, MD Arizona Pharmacy Foundation Peggy Khan, Pharm.D., BCPS Pam Coumans, Pharm.D. Prescription
More informationCannabis Legalization August 22, Ministry of Attorney General Ministry of Finance
Cannabis Legalization August 22, 2018 Ministry of Attorney General Ministry of Finance Federal Cannabis Legalization and Regulation The federal Cannabis Act received Royal Assent on June 21, 2018 and will
More informationFalsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin
Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin Objectives What is FMD all about and when does it need to happen? Who are SecurMed and what is our role
More informationTHE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
More informationInternet Drug Sellers: What Providers Need to Know
Internet Drug Sellers: What Providers Need to Know A program sponsored by the Federation of State Medical Boards and the Alliance for Safe Online Pharmacies Accredited for CME and CPE Program Faculty Tim
More informationCounterfeit Drugs Affect Even Legitimate Sources: Hospitals and Pharmacies
Counterfeit Drugs Affect Even Legitimate Sources: Hospitals and Pharmacies Charlie Cichon, Executive Director National Association of Drug Diversion Investigators Homeland Security 2014 Each year, more
More informationVirtual Mentor American Medical Association Journal of Ethics July 2009, Volume 11, Number 7:
Virtual Mentor American Medical Association Journal of Ethics July 2009, Volume 11, Number 7: 492-497. CLINICAL CASE Prohibitive Cost of HIV/AIDS Therapy in the United States Commentary by Jennifer Cohn,
More informationProf. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law
Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law SSFFC drugs are medical products that: do not contain any specific active substances, irrespective of the indication
More informationAvoiding Rogue Internet Pharmacy Suppliers in the Effort to Improve Access to Medicines
Avoiding Rogue Internet Pharmacy Suppliers in the Effort to Improve Access to Medicines July 26, 2018 Jillian Clare Kohler PhD Director, WHO Collaborating Centre for Governance, Accountability and Transparency
More informationInternet Drug Outlet Identification Program
Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: July 2011 TABLE OF CONTENTS I. INTRODUCTION... 3 II. RESULTS... 4 A. Findings of Site Reviews... 4 B. Recommended
More information6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES
CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and
More informationCANNABIS MANAGEMENT CORPORATION REGULATIONS
c t CANNABIS MANAGEMENT CORPORATION REGULATIONS PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this regulation, current to August 11, 2018. It is intended
More informationHealth Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:
Health Authority Abu Dhabi Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: PPR/DMP/DR/P0001 Version 0.9 Approval Date: August 2007 Effective Date: August 2007 Last
More informationRULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-17 DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS 1140-17-.01 Definitions 1140-17-.02 Purpose 1140-17-.03 Eligibility Criteria for Program Participation
More informationStates with Authority to Require Nonresident Pharmacies to Report to PMP
States with Authority to Require Nonresident Pharmacies to Report to PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis February 2018 I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize,
More informationGuideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
More informationPharmaceutical Producer Responsibility Ordinances
Pharmaceutical Producer Responsibility Ordinances SAN FRANCISCO, SAN MATEO, SANTA CLARA & MARIN COUNTIES NOVEMBER 4, 2015 WEBINAR This webinar is being recorded PLEASE BE ADVISED Information provided in
More informationFDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update
FDLI s Enforcement, Litigation, and Compliance Conference Center for Tobacco Products Office of Compliance and Enforcement 2017 Update Ann Simoneau, Director Office of Compliance and Enforcement Center
More informationJuly 6, Dear Governor Christie:
July 6, 2017 The Honorable Chris Christie Chair President s Commission on Combating Drug Addiction and the Opioid Crisis White House Office of National Drug Control Policy 750 17th Street, N.W. Washington,
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO ) ) ) ) ) ) ) ) ) INFORMATION. General Allegations. A. Introduction and Background
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO UNITED STATES OF AMERICA, Plaintiff, vs. MOHAMED BASEL ASWAD, M.D., Defendant. CRIMINAL NO. 21 U.S.C. 331(a and 333(a(1: Introduction
More informationResponsible Retailing of Recreational Cannabis. Recommendations to British Columbia s Cannabis Regulation Engagement Secretariat
Responsible Retailing of Recreational Cannabis Recommendations to British Columbia s Cannabis Regulation Engagement Secretariat Introduction On behalf of British Columbia s Alliance of Beverage Licensees
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize, regulate
More informationCounterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd.
Counterfeit Medicinal Products FINLAND Roschier, Attorneys Ltd. CONTACT INFORMATION Mikael Segercrantz Robert Hagelstam Roschier, Attorneys Ltd. Keskuskatu 7 A 00100 Helsinki, Finland 358.20.506.6000 mikael.segercrantz@roschier.com
More informationUnderstanding the New Access to Cannabis for Medical Purposes Regulations
Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners
More informationIdaho State Police Alcohol Beverage Control
Idaho State Police Alcohol Beverage Control LEO Training 2016 Safety 67% of people in America drink alcohol 58 % of high school graduates drink alcohol 44% of college students binge drink 48% of college
More informationWalgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs
Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion
More informationThe Spreading Plague of Counterfeiting
The Spreading Plague of Counterfeiting Harvey Bale Director General International Federation of Pharmaceutical Manufacturers Associations (IFPMA) PSF Assembly Stockholm 25 October 2003 Rising Tide of a
More informationFor personal use only
AusCann Makes Major Progress Towards Production of Cannabinoid Medicines During FY18 Highlights Undertook comprehensive pharmaceutical development project to create an optimal dosage form cannabinoid medicine
More informationReview of Controlled Drugs and Substances Act
Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A
More informationPHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS
PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS For Producer Audience Only - Please Do Not Distribute Regence has selected Prime Therapeutics as the Pharmacy benefits manager for its health plans.
More information(4) Be as detailed as necessary to provide history of work performed; and:
www.omarfigueroa.com Page 66 of 278 (4) Be as detailed as necessary to provide history of work performed; and: (A) Include information adequate to identify any associated manufacturing facility (e.g.,
More informationTHE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and
THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and effective. Before any drug is approved for marketing
More informationBackground COUNTERFEITING DRUGS IS MURDER CURRENT NATIONAL LEGISLATIVE RESPONSES. 8-15% of global pharmaceutical sales is counterfeit
COUNTERFEITING DRUGS IS MURDER CURRENT NATIONAL LEGISLATIVE RESPONSES Michael H. Anisfeld Globepharm Consulting, USA Michael H. Anisfeld Globepharm Consulting 313 Pine Street Deerfield IL 60015, USA Phone:
More informationCannabis Legalization and Regulation in British Columbia Discussion Paper
Cannabis Legalization and Regulation in British Columbia Discussion Paper Introduction In 2015, the federal government committed to legalizing non-medical cannabis in Canada. On June 30, 2016, it established
More informationGlobalization of the Illicit Online Drug Supply Chain: Potential Risks to Patients and Pets
Timothy K. Mackey, MAS 31 st Annual Meeting Society of Veterinary Hospital Pharmacists May 2012 Globalization of the Illicit Online Drug Supply Chain: Potential Risks to Patients and Pets Pre Test Question
More informationDRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT
c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended
More informationEffective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Products
Effective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Quick Facts Retailers that mix and prepare e-liquids or create or modify vaporizers
More informationOrganization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.
Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Mexico 2009 EVALUATION OF PROGRESS IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS
More informationCounterfeit Medicinal Products. POLAND Wardyński & Partners
Counterfeit Medicinal Products POLAND Wardyński & Partners CONTACT INFORMATION Ewa Butkiewicz, Ph.D. Wardyński & Partners Al. Ujazdowskie 10 00-478 Warsaw, Poland 48.22.437.82.00 ewa.butkiewicz@wardynski.com.pl
More informationLegalization of Cannabis: The Way Forward
Percent 2018/05/03 Legalization of Cannabis: The Way Forward W. O. McCormick Academic Day Hon. A. Anne McLellan, PC, OC, AOE Friday, April 27 2018 Current Context 40 Past year cannabis use, by age group,
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationGOVERNMENT S ROLE IN ADDRESSING PRESCRIPTION DRUG ABUSE
POSITION PAPER GOVERNMENT S ROLE IN ADDRESSING PRESCRIPTION DRUG ABUSE Governments across Canada are concerned about the abuse of prescription drugs, with recent policy discussions focused on mitigating
More informationStandards, Education, Verification. Patient Focused Certification
Standards, Education, Verification Patient Focused Certification PFC Training helps you achieve quality standards. Staff Certification is now available online www.pfctraining.org jahan@safeaccessnow.org
More informationMedia Contacts: Kelley Dougherty Investor Contact: Graeme Bell (215) (908)
News Release Media Contacts: Kelley Dougherty Investor Contact: Graeme Bell (215) 652-0059 (908) 423-5185 Janet Skidmore (267) 305-7715 Merck Launches National Advertising Campaign for GARDASIL, Merck's
More informationEVALUATION OF RISK PERCEPTION ASSOCIATED WITH ONLINE PHARMACY USE
EVALUATION OF RISK PERCEPTION ASSOCIATED WITH ONLINE PHARMACY USE John Hertig PharmD, MS,*, Chelsea Anderson PharmD, MBA, BCPS*, Catherine Scott, CPHQ,* Kathryn Marwitz PharmD, MPH,** Kiersten Walters
More information2015 Exam Committees Report for the National Physical Therapy Examination Program
2015 Exam Committees Report for the National Physical Therapy Examination Program Executive Summary This report provides a summary of the National Physical Therapy Examination (NPTE) related activities
More informationReport. Uganda Pharmaceutical Sector Scan JUNE 2010
Report On the Uganda Pharmaceutical Sector Scan Part of Component 1 of MeTA Baseline Assessments JUNE 2010 Drafted by consultants: 1. Samuel Balyejjusa, B.Pharm., MPH 2. Paschal Mujasi, B.Pharm., MBA 3.
More informationAWARD DESCRIPTION AND APPLICATION PACKAGE
AWARD DESCRIPTION AND APPLICATION PACKAGE Award Description Recipient: a graduating student from a Canadian School of Pharmacy Purpose: The purpose of this award is to recognize a graduating student who
More informationARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH
ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH 1.0 INTRODUCTION Arkansas State University (ASU) is committed to enhancing the growth of research and other
More informationCannabis Regulation in Canada:
Cannabis Regulation in Canada: Where We Came From, Where We Are and What s Coming Next Jonathan Sherman Cassels Brock & Blackwell LLP Sherri Altshuler Aird & Berlis LLP Canada, In Brief Right Now... Legal
More informationNitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam
Nitrazepam, Nitrazepam India, Nitrazepam manufacturers India, side effects Nitrazepam manufacturers, Taj Pharma India, Nitrazepam overdose, Nitrazepam drug, Nitrazepam composition, Manufacturing Pharmaceutical,
More informationH 7816 S T A T E O F R H O D E I S L A N D
LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, Canario,
More informationPerformance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
More informationAN OPTIMAL REGULATORY MIX FOR METHAMPHETAMINE PRECURSORS?
AN OPTIMAL REGULATORY MIX FOR METHAMPHETAMINE PRECURSORS? Janet Ransley Griffith University Responding to methamphetamine problems How should governments respond to the problem of domestic, illicit production
More information2007 FIP World Congress of Pharmacy and Pharmaceutical Sciences September 3, 2007 Beijing, China
2007 FIP World Congress of Pharmacy and Pharmaceutical Sciences September 3, 2007 Beijing, China Topic: International Trade Issues Related to Counterfeit Medicines and the Need for Global Cooperation Jeffrey
More informationSECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
More informationQUESTIONS AND ANSWERS Access to Drugs in Exceptional Circumstances
QUESTIONS AND ANSWERS Access to Drugs in Exceptional Circumstances Published by authority of the Minister of Health Date Adopted 2017/06/09 Effective Date 2017/06/28 Health Products and Food Branch Our
More informationLEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017
LEERINK GLOBAL HEALTHCARE CONFERENCE Marino Garcia EVP, Chief Strategy Officer February 15, 2017 SAFE HARBOR STATEMENT This presentation and any statements made for and during any presentation or meeting
More informationPLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.
PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to July 1, 2012. It is intended for information and reference purposes only. This
More informationCrowe Healthcare Webinar Series
Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President
More informationAlthough PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.
NASCSA Statement for the Record as presented by Barbara A Carter, President, NASCSA Submitted to: Department of Health and Human Services, Food and Drug Administration, Opioid Policy Steering Committee
More informationAppearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse
Opening Statement Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse Dr. Chris Simpson, President-elect
More informationAmerican Emu Association. Certified Emu Oil Program
Table of Contents Part 1. Frequently Asked Questions... 3 Part 2. AEA Certified Fully Refined Seal & Verbiage Usage Requirements... 5 Section A. Program Requirements... 5 Section B. Product Labeling Requirements...
More informationPhilippine Strategy for the. Free Alternatives. under the National CFC Phase-out Plan (NCPP)
Philippine Strategy for the Transition from CFCcontaining MDIs to CFC- Free Alternatives under the National CFC Phase-out Plan (NCPP) 1 Developing the Transition Strategy Findings of the study of the MDIs
More informationFAQ. A. No, Nature s Ultra products are formulated with a CBD isolate, which by definition contains no THC.
Q. What is Nature s Ultra? A. Nature s Ultra is a third-party company using Young Living essential oils to infuse many of its CBD products. Its products are produced from a farm in Colorado using sustainable
More informationRxVACCINATE: A National Education and Practice Support Initiative to Increase Pharmacist Administered Pneumococcal Vaccinations.
RxVACCINATE: A National Education and Practice Support Initiative to Increase Pharmacist Administered Pneumococcal Vaccinations. Pfizer Grant 45130: LOI Pneumococcal Disease Prevention Grant ID: 45130
More informationWe would be pleased to answer questions you may have about our submission.
Memorandum Date: October 24, 2017 To: Cannabis Secretariat of British Columbia From: Cannabis Canada Association Subject: Response to Public Consultations on Cannabis Legalization Introduction The Government
More informationWelcome and Overview. Learning Objectives
Welcome and Overview Eleni Z. Anagnostiadis, RPh Associate Executive Director National Association of Boards of Pharmacy Mount Prospect, Illinois Learning Objectives Upon completion of this activity, participants
More informationFood Safety Modernization Act - Impacts on the Grain and Feed Industry
Food Safety Modernization Act - Impacts on the Grain and Feed Industry NGFA 117th Annual Meeting and Convention March 17, 2013 San Francisco, California David Fairfield, NGFA Vice President of Feed Services
More informationLOGO. Falsification of Medicines. Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry
LOGO Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry Falsification of Medicines Dr. As. Prof. Anastasiya Sladkova Dr. Sci. Prof. Natalya Loginova 1 Questions
More informationFDA Food Safety Modernization Act (FSMA) January 4, 2011
FDA Food Safety Modernization Act (FSMA) January 4, 2011 FDA Food Safety Modernization Act (FSMA) The Most Sweeping Reform of the U.S. Food Safety Laws in More than 70 Years FDA Food Safety Modernization
More informationStrategies for Federal Agencies
Confronting Pain Management and the Opioid Epidemic Strategies for Federal Agencies Over the past 25 years, the United States has experienced a dramatic increase in deaths from opioid overdose, opioid
More informationSupporting Trading Standards to tackle illicit tobacco. Richard Ferry, Fresh Kate Pike, Tobacco Free Futures Smokefree South West
Supporting Trading Standards to tackle illicit tobacco Richard Ferry, Fresh Kate Pike, Tobacco Free Futures Smokefree South West What we ll cover 1. What is illicit tobacco and why is it an issue? 2. The
More informationOverview of Current Medicine Take-Back Efforts
Overview of Current Medicine Take-Back Efforts Margaret Shield PhD Community Environmental Health Strategies LLC www.cehstrategies.com 206-499-5452 margaret.shield@cehstrategies.com June 16, 2017 Secure
More informationLAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY
LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY President s Office No. 13/PO DECREE of the PRESIDENT of the LAO PEOPLE S DEMOCRATIC REPUBLIC On the Promulgation of the Law
More informationDARA Reports Year-End 2012 Financial Results
April 1, 2013 DARA Reports Year-End 2012 Financial Results Company Provides a Commercial Portfolio and Development Pipeline Business Update RALEIGH, NC -- (MARKETWIRE) -- 04/01/13 -- DARA BioSciences,
More informationGuidance for Municipalities Regarding Marijuana for Adult Use January 2018
Guidance for Municipalities Regarding Marijuana for Adult Use January 2018 The following information is provided to assist municipalities by addressing questions related to the regulation of marijuana
More informationSupplier Code of Business Conduct
Supplier Code of Business Conduct We act with integrity, honesty and respect. Sempra Energy Values We are an ethical, respectful, high performing, forward looking, responsible partner. Our values define
More informationMitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association
Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center
More informationCARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:
RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription
More informationBritish American Tobacco Snus Marketing Standards
British American Tobacco Snus Marketing Standards British American Tobacco p.l.c. believes there is sufficient scientific evidence to support a less restrictive regime for the advertising and promotion
More informationCanadian Association of Chiefs of Police. Drug Abuse Committee. Annual Report
Canadian Association of Chiefs of Police Drug Abuse Committee Annual Report Submitted by: Chief Mark Mander, Chair Message from the Chair: In November 2012, I was elected Chair of the committee and Eric
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationHISTORY, CAPACITY AND POSITION
HISTORY, CAPACITY AND POSITION A high level presentation for SAPRAA April 2017 History Founded in 1976, the HPA has efficiently supported, promoted and protected the CAMs industry for 40 years. The HPA
More informationGENERAL INFORMATION AND INSTRUCTIONS
NON-PARTICIPATING MANUFACTURER CERTIFICATION FOR LISTING ON OREGON DIRECTORY GENERAL INFORMATION AND INSTRUCTIONS Who is required to file this Certification? Any tobacco product manufacturer who is a non-participating
More informationGuideline on the Regulation of Therapeutic Products in New Zealand
Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0 January 2016 Section 1: Legislation Section summary This
More information